NEW BEVA MEDICAL
ActiveNEW BEVA MEDICAL has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show negative equity (€-27k) and a net result of €-30k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
44
/ 100
Weak
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Negative equity caps the score. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability12▼-64
Solvency8▼-18
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.7 against 0.79 in 2023; short-term debt: 117.1% and cash: 82.2% of total assets), and equity is negative.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
-17.1%
Return on assets
-19%
Age of the figures
21 mo
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024Equity per financial year
18192021222324
2018 to 2024 · latest year €-27k
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-12-2025, 152 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 8 filingsDeviation from the deadline
2025
not confirmed
2024
152 d late
2023
153 d late
2022
91 d late
2021
31 d late
2020
396 d late
2019
194 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€-27k
2023 · €3k
2018: €-31k
2019: €-7k
2020: €13k
2021: €45k
2022: €-8k
2023: €3k
2018 → 2024
Total assets
€160k▼ 23.0%
2023 · €208k
2018: €139k
2019: €113k
2020: €97k
2021: €187k
2022: €213k
2023: €208k
2018 → 2024
Net result
€-30k
2023 · €11k
2018: €-19k
2019: €24k
2020: €21k
2021: €32k
2022: €-53k
2023: €11k
2018 → 2024
Working capital
€-56k▼ 31.6%
2023 · €-43k
2018: €-14k
2019: €-17k
2020: €6k
2021: €10k
2022: €-50k
2023: €-43k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€13k-€45k▲ 236%€-8k€3k€-27k
Operating result€26k-€45k▲ 70.9%€-45k€32k€-8k
Net result€21k-€32k▲ 54.6%€-53k€11k€-30k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2024: a loss of €8k after €32k in 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €159k
Fixed assets
€27k▼ 40.3%
Current assets
€132k▼ 19.1%
Key figures and ratios
EBITDA
€8k▼
2023 · €50k
Cash flow
€-14k▼
2023 · €29k
Solvency
-17.1%▼
2023 · 1.4%
Current ratio
0.70▼
2023 · 0.79
Quick ratio
0.70▼
2023 · 0.79
Debt / equity
-6.84▼
2023 · 68.50
ROA
-19.0%▼
2023 · 5.4%
Interest coverage
1.48▼
2023 · 7.26
Debt
€188k▼
2023 · €205k
Debt ≤ 1 year
€188k▼
2023 · €205k
Income taxes
€16k▲
2023 · €14k
Staff costs
€86k▼
2023 · €98k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€208k€160k▼
Formation expenses20-€1k
Fixed assets21/28€46k€27k▼
Tangible fixed assets22/27€43k€24k▼
Furniture and vehicles24€27k€14k▼
Other tangible fixed assets26€14k€10k▼
Assets under construction and advance payments27€2k-
Financial fixed assets28€3k€3k=
Current assets29/58€163k€132k▼
Cash at bank and in hand54/58€163k€132k▼
Equity and liabilities
Total equity and liabilities10/49€208k€160k▼
Equity10/15€3k€-27k▼
Contributions10/11€6k€6k=
Profit (loss) carried forward14€-3k€-34k▼
Amounts payable17/49€205k€188k▼
Amounts payable within one year42/48€205k€188k▼
Current portion of amounts payable after more than one year42€3k€3k=
Trade debts44€161k€156k▼
Suppliers440/4€161k€156k▼
Taxes, remuneration and social security45€21k€28k▲
Taxes450/3€2k€16k▲
Remuneration and social security454/9€19k€11k▼
Other amounts payable47/48€21k€1k▼
Income statement
Code20232024
Non-recurring operating income76A-€243
Remuneration, social security and pensions62€98k€86k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€18k€17k▼
Other operating charges640/8€3k€0▼
Gross operating margin9900€151k€95k▼
Operating profit (loss)9901€32k€-8k▼
Financial charges65/66B€7k€6k▼
Recurring financial charges65€7k€6k▼
Profit (loss) for the period before taxes9903€25k€-14k▼
Income taxes67/77€14k€16k▲
Profit (loss) for the period9904€11k€-30k▼
Profit (loss) for the period to be appropriated9905€11k€-30k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-3k€-34k▼
Profit (loss) brought forward from the previous period14P€-14k€-3k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-12
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 152 days late
2024
31-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 153 days late
2023
31-12
Financial
Back to profitnet €11k
Net result €11k after one loss-making year.
30-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 91 days late
2022
31-12
Financial
Weakest financial yearnet €-53k ▼267%
Net result drops to €-53k, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 396 days late
2021
31-12
Financial
Highest result since 2018net €32k ▲54.6%
Operating result €45k, net result €32k, both a record.
10-02
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 194 days late
2019
31-12
Financial
Back to profitnet €24k
Net result €24k after one loss-making year.
31-12
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 153 days late
2018
31-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, La Louvière · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Oscar Quertinmont(TRI) 1027100 La LouvièreGround area
541 m²
Building footprint
45 m²
Volume, LiDAR
402 m³
Parcel 55046C0101/00V002, Wallonia · tallest building 10.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Rue Oscar Quertinmont(TRI) 102, 7100 La Louvière
since 20172.263.935.359
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 55046C0101/00V002 | Wallonia | 541 m² | 1 · 45 m² | 10.3 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DOKTER TYRONE DEVOLDER
BE 0697.804.637
Kortrijk · Eq €3k
Dokter Van Deun Thomas
BE 0721.508.269
Kontich · Eq €3k
DR. CATHERINE THEUWIS
BE 0729.737.037
Alken · Eq €3k
Dr. Tessa Vande Velde
BE 0730.852.438
Heist-op-den-Berg · Eq €3k
DOKTER PHEANDRA DE WACHTER
BE 0730.975.964
Wuustwezel · Eq €3k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 1,025 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-03-2017
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.